A recent Scandinavian study led by researchers at Karolinska Institutet has found no evidence of a link between GLP-1 analog drugs and thyroid cancer. GLP-1 analogs are commonly used to treat diabetes and obesity, and concerns had been raised about their potential risk. However, the study's findings provide reassurance regarding this potential side effect.
Apr 9 2024 Karolinska Institutet Drugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase the risk of thyroid cancer . Now an extensive Scandinavian study led by researchers at Karolinska Institutet has found no evidence of such a link. The study is published in The BMJ.
"Many people take these medicines, so it is important to study potential risks associated with them," says Björn Pasternak, principal researcher at the Department of Medicine, Solna, at Karolinska Institutet in Sweden. "Our study covers a broad group of patients and provides strong support that GLP-1 analogs are not associated with an increased risk of thyroid cancer."
GLP-1 treatment was not associated with an increased risk of thyroid cancer. The results were consistent also when compared to a third diabetes medication group . Related StoriesThe ongoing research program at Karolinska Institutet investigates the effects and potential side effects of newer diabetes medications such as GLP-1 analogs and SGLT2 inhibitors. These medications are now being used to treat broader patient groups, including those with obesity, heart failure, and kidney failure.
GLP-1 Analogs Diabetes Obesity Thyroid Cancer Study Karolinska Institutet
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Study adds new evidence on the link between Type 2 diabetes and Alzheimer's diseaseNew research conducted in mice offers insights into what's going on at the molecular level that could cause people with diabetes to develop Alzheimer's disease.
続きを読む »
Preoperative GLP-1 agonist use does not increase aspirationPreoperative glucagon-like peptide-1 (GLP-1) agonist use does not increase the risk for aspiration or subsequent pneumonia in patients undergoing various surgical procedures, according to a study presented at the 49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting, held from March 21 to 23 in San Diego.
続きを読む »
AANA issues considerations for GLP-1 receptor agonist use before surgeryConsiderations for anesthesia care in relation to use of glucagon-like peptide-1 (GLP-1) receptor agonists before surgery are addressed in a report published March 11 by the American Association of Nurse Anesthesiology (AANA).
続きを読む »
Popular diabetes drugs do not increase thyroid cancer risk, study suggestsDrugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase the risk of thyroid cancer. Now an extensive Scandinavian study led by researchers at Karolinska Institutet has found no evidence of such a link. The study is published in The BMJ.
続きを読む »
A New Study Just Added More Devastating Evidence To The Kids And Smartphones DebateAccording to a recent study, one in ten boys aged 11-14 with their own smartphone are seeing harmful content within just 60 seconds of being online. Read more on Grazia...
続きを読む »
Good evidence confuses ChatGPT when used for health information, study findsA world-first study has found that when asked a health-related question, the more evidence that is given to ChatGPT, the less reliable it becomes—reducing the accuracy of its responses to as low as 28%.
続きを読む »